Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Bell

Showing results (1-10 of 199) with videos related to

Pageof 20
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 19, 2020
Check and Checkmate: Battling Cancer with Multiplex ImmunotherapyJohn C Bell
Mayo Clinic Proceedings|May 20, 2014
Taming measles virus to create an effective cancer therapeuticJohn C Bell
Science Translational Medicine|June 16, 2012
The virus that came in from the coldJohn C Bell
Current Cancer Drug Targets|March 10, 2007
Oncolytic viruses: what's next?John C Bell
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 3, 2011
Interfering with tumor pathways that augment viral oncolysisJohn C Bell
Future Oncology (London, England)|December 14, 2011
Oncolytic viruses: smart therapeutics for smart cancersRebecca Auer, John C Bell
Iranian Biomedical Journal|December 7, 2007
Intercellular trafficking of VP22, a herpes simplex virus type 1 tegument proteinTaravat Bamdad, John C Bell
Cell Cycle (Georgetown, Tex.)|January 16, 2007
Novel therapeutic target: the PERKs of inhibiting the integrated stress responseJaime Blais, John C Bell
Nature Biotechnology|December 9, 2008
MicroRNAs fine-tune oncolytic virusesJohn C Bell, David Kirn
Current Opinion in Virology|August 12, 2015
Editorial overview: Oncolytic viruses--replicating virus therapeutics for the treatment of cancerJohn C Bell, Grant McFadden
Pageof 20

Showing results (1-10 of 199) with videos related to

Sort By:
Pageof 20
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 19, 2020
Check and Checkmate: Battling Cancer with Multiplex ImmunotherapyJohn C Bell
Mayo Clinic Proceedings|May 20, 2014
Taming measles virus to create an effective cancer therapeuticJohn C Bell
Science Translational Medicine|June 16, 2012
The virus that came in from the coldJohn C Bell
Current Cancer Drug Targets|March 10, 2007
Oncolytic viruses: what's next?John C Bell
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 3, 2011
Interfering with tumor pathways that augment viral oncolysisJohn C Bell
Future Oncology (London, England)|December 14, 2011
Oncolytic viruses: smart therapeutics for smart cancersRebecca Auer, John C Bell
Iranian Biomedical Journal|December 7, 2007
Intercellular trafficking of VP22, a herpes simplex virus type 1 tegument proteinTaravat Bamdad, John C Bell
Cell Cycle (Georgetown, Tex.)|January 16, 2007
Novel therapeutic target: the PERKs of inhibiting the integrated stress responseJaime Blais, John C Bell
Nature Biotechnology|December 9, 2008
MicroRNAs fine-tune oncolytic virusesJohn C Bell, David Kirn
Current Opinion in Virology|August 12, 2015
Editorial overview: Oncolytic viruses--replicating virus therapeutics for the treatment of cancerJohn C Bell, Grant McFadden
Pageof 20